AbLearning™ - Episode 3: Chimeric Antigen Receptor T Cell Therapy
AbLearning™ Educational Program hosted by Abnova.
Chimeric antigen receptor (CAR) T cell therapy has stirred a hot debate in clinic since the first CAR T cell therapy for ALL got approval from FDA in August 2017. Let's get into know this treatment and realize how it works.
Any questions? Feel free to contact us.
https://www.abnova.com/aboutus/contac...
Follow us on the social media!
Facebook: / abnova1
LinkedIn: / 504542
Twitter: / abnova1
Watch video AbLearning™ - Episode 3: Chimeric Antigen Receptor T Cell Therapy online without registration, duration hours minute second in high quality. This video was added by user Abnova 21 December 2017, don't forget to share it with your friends and acquaintances, it has been viewed on our site 2,956 once and liked it 29 people.